Human Financial Statements From 2010 to 2024

HUMX Stock  ILA 29.10  0.20  0.69%   
Human Xtensions financial statements provide useful quarterly and yearly information to potential Human Xtensions investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Human Xtensions financial statements helps investors assess Human Xtensions' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Human Xtensions' valuation are summarized below:
Human Xtensions does not presently have any fundamental trends for analysis.
Check Human Xtensions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Human Xtensions' main balance sheet or income statement drivers, such as , as well as many indicators such as . Human financial statements analysis is a perfect complement when working with Human Xtensions Valuation or Volatility modules.
  
This module can also supplement various Human Xtensions Technical models . Check out the analysis of Human Xtensions Correlation against competitors.

Human Xtensions Company Operating Margin Analysis

Human Xtensions' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Human Xtensions Operating Margin

    
  (14.93) %  
Most of Human Xtensions' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Human Xtensions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Human Xtensions has an Operating Margin of -14.9251%. This is 57.45% lower than that of the Healthcare sector and 62.03% lower than that of the Medical Devices industry. The operating margin for all Israel stocks is 170.87% higher than that of the company.

Human Xtensions Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Human Xtensions's current stock value. Our valuation model uses many indicators to compare Human Xtensions value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Human Xtensions competition to find correlations between indicators driving Human Xtensions's intrinsic value. More Info.
Human Xtensions is rated # 2 in return on equity category among its peers. It also is rated # 2 in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Human Xtensions by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Human Xtensions' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Human Xtensions Financial Statements

Human Xtensions stakeholders use historical fundamental indicators, such as Human Xtensions' revenue or net income, to determine how well the company is positioned to perform in the future. Although Human Xtensions investors may analyze each financial statement separately, they are all interrelated. For example, changes in Human Xtensions' assets and liabilities are reflected in the revenues and expenses on Human Xtensions' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Human Xtensions. Please read more on our technical analysis and fundamental analysis pages.
It offers HandX, a handheld medical device for use in laparoscopic procedures. The company was founded in 2012 and is based in Netanya, Israel. HUMAN XTENSIONS operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 58 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Human Stock

Human Xtensions financial ratios help investors to determine whether Human Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Human with respect to the benefits of owning Human Xtensions security.